Bright-light treatment ameliorates motor and non-motor deficits through distinct visual circuits in a mouse model of Parkinson's disease

Area of Science:

• Neuroscience
• Ophthalmology
• Neurodegenerative Diseases

Background:

• Bright-light therapy shows promise for Parkinson's disease (PD) symptom management.
• The underlying neural pathways for light therapy's effects in PD are not well understood.

Purpose of the Study:

• To elucidate the specific neural circuits mediating the therapeutic effects of bright light in a mouse model of PD.
• To differentiate the mechanisms for alleviating motor versus non-motor PD symptoms.

Main Methods:

• Investigated the role of distinct visual pathways (ventral lateral geniculate nucleus and superior colliculus-substantia nigra pars compacta) in response to bright-light treatment in PD mice.
• Analyzed changes in neuronal activity and gene expression (HCN2) in specific brain regions.

Main Results:

• Bright light alleviates non-motor PD symptoms (depressive-like behavior, spatial memory deficits) via the ventral lateral geniculate nucleus.
• Motor symptom improvement is linked to a pathway involving the superior colliculus and substantia nigra pars compacta (SNc).
• Bright light enhances SNc dopaminergic neuron activity by upregulating HCN2 expression, crucial for motor recovery.

Conclusions:

• Bright-light therapy benefits PD through separate visual circuits for motor and non-motor symptoms.
• The superior colliculus-SNc pathway and HCN2 upregulation are key mechanisms for light-induced motor improvements in PD.
• Findings provide a mechanistic basis for bright-light therapy in Parkinson's disease treatment.